Diabetic Macular Edema (DME) Recruiting Phase Trials for Aflibercept (DB08885)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Macular edema due to diabetes mellitus (disorder) / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02669953Aflibercept in Recurrent or Persistent CNV
NCT05222633Anti-VEGF in Real-world